Canada markets closed

Talis Biomedical Corporation (TLIS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
8.91-0.09 (-1.00%)
At close: 04:00PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-57,211
-62,007
-113,012
-192,036
-91,130
Depreciation & amortization
858
770
8,830
1,578
763
Stock based compensation
3,769
4,351
5,368
9,207
3,683
Change in working capital
-2,277
-3,424
-7,686
8,824
-951
Accounts receivable
120
259
-125
288
-238
Accounts Payable
-1
-2,429
-1,194
216
3,200
Other working capital
-43,664
-53,726
-101,751
-174,250
-95,225
Other non-cash items
3,922
4,304
2,771
1,043
611
Net cash provided by operating activites
-43,202
-53,240
-100,136
-171,384
-87,024
Cash flows from investing activities
Investments in property, plant and equipment
-
-486
-1,615
-2,866
-8,201
Net cash used for investing activites
-432
-486
-1,615
-2,866
-8,201
Cash flows from financing activities
Common stock issued
-
-
0
232,546
0
Other financing activites
-
-
-
-
-1,451
Net cash used privided by (used for) financing activities
2
33
406
234,429
246,754
Net change in cash
-43,632
-53,693
-101,345
60,179
151,529
Cash at beginning of period
115,511
131,967
233,312
173,133
21,604
Cash at end of period
71,879
78,274
131,967
233,312
173,133
Free Cash Flow
Operating Cash Flow
-43,202
-53,240
-100,136
-171,384
-87,024
Capital Expenditure
-
-486
-1,615
-2,866
-8,201
Free Cash Flow
-43,664
-53,726
-101,751
-174,250
-95,225